How did OPTN's Q4 earnings surprise impact investor sentiment?

**OptiNose's (OPTN) Q4 earnings surprise had a positive impact on investor sentiment**, as evidenced by several key indicators: 1. **Revenue Surprise**: OptiNose reported a revenue surprise of $1.4 million for Q4 2024. This positive surprise likely contributed to investor optimism, as it indicated the company's performance exceeded market expectations. 2. **Earnings Surprise**: The company reported an earnings surprise of $0.73 per share, which is a significant positive indicator. Investors often view earnings surprises positively, as they suggest that the company's financial performance is better than anticipated. 3. **Analyst Price Targets and Ratings**: The average analyst price target for OPTN is $11, with a consensus rating of "Neutral". The fact that the stock is currently trading below the average analyst price target suggests that analysts believe there is potential for the stock to increase in value, which could have boosted investor confidence. 4. **Recent News**: OptiNose's announcement of a reverse stock split to meet Nasdaq rules may have initially led to some negative sentiment. However, the company's strategic move to address the stock's low price and maintain its Nasdaq listing could be seen as a positive step by some investors. 5. **Acquisition News**: The news of OptiNose's acquisition by Paratek Pharmaceuticals for $330 million has likely had a significant positive impact on investor sentiment. The substantial acquisition price and the potential for OPTN's product to be more widely distributed through Paratek's commercial infrastructure could be seen as a major endorsement of the company's value and growth potential. Overall, the combination of the revenue and earnings surprises, the analyst price targets, and the acquisition news likely contributed to a positive sentiment around OptiNose's Q4 earnings report.